Results 201 to 210 of about 7,937 (220)
Some of the next articles are maybe not open access.
Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Chemical Reviews, 2021Dieter Willbold +2 more
exaly
Vutrisiran (Amvuttra) for Transthyretin Amyloid Cardiomyopathy
The Medical Letter on Drugs and TherapeuticsThe FDA has approved vutrisiran (Amvuttra – Alnylam), a subcutaneously injected small interfering RNA (siRNA), to reduce cardiovascular hospitalizations, urgent heart failure visits, and cardiovascular death in adults with wild-type or variant transthyretin amyloid cardiomyopathy (ATTR-CM).
openaire +1 more source
Mechanisms and pathology of protein misfolding and aggregation
Nature Reviews Molecular Cell Biology, 2023Nikolaos N Louros, Frederic Rousseau
exaly
Tafamidis (Vyndaqel; Vyndamax) for Transthyretin Amyloid Cardiomyopathy
JAMA, 2020openaire +2 more sources
The amyloid state and its association with protein misfolding diseases
Nature Reviews Molecular Cell Biology, 2014Tuomas P J Knowles +2 more
exaly
A new era for understanding amyloid structures and disease
Nature Reviews Molecular Cell Biology, 2018Matthew G Iadanza +2 more
exaly
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
Science, 2002John Hardy
exaly
Therapeutic strategies for human amyloid diseases
Nature Reviews Drug Discovery, 2002James C Sacchettini
exaly